77 related articles for article (PubMed ID: 18779673)
21. Black cohosh extracts in women with menopausal symptoms: an updated pairwise meta-analysis.
Sadahiro R; Matsuoka LN; Zeng BS; Chen KH; Zeng BY; Wang HY; Chu CS; Stubbs B; Su KP; Tu YK; Wu YC; Lin PY; Chen TY; Chen YW; Suen MW; Hopwood M; Yang WC; Sun CK; Cheng YS; Shiue YL; Hung CM; Matsuoka YJ; Tseng PT
Menopause; 2023 Jul; 30(7):766-773. PubMed ID: 37192826
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of a standardized isopropanolic black cohosh (Actaea racemosa) extract in treatment of uterine fibroids in comparison with tibolone among patients with menopausal symptoms.
Ross SM
Holist Nurs Pract; 2014; 28(6):386-91. PubMed ID: 25314113
[TBL] [Abstract][Full Text] [Related]
23. No evidence black cohosh helps with hot flashes.
Harv Womens Health Watch; 2012 Dec; 20(4):8. PubMed ID: 23346619
[No Abstract] [Full Text] [Related]
24. Black cohosh has central opioid activity in postmenopausal women: evidence from naloxone blockade and positron emission tomography neuroimaging.
Reame NE; Lukacs JL; Padmanabhan V; Eyvazzadeh AD; Smith YR; Zubieta JK
Menopause; 2008; 15(5):832-40. PubMed ID: 18521048
[TBL] [Abstract][Full Text] [Related]
25. Liver failure associated with the use of black cohosh for menopausal symptoms.
Chow EC; Teo M; Ring JA; Chen JW
Med J Aust; 2008 Apr; 188(7):420-2. PubMed ID: 18393750
[No Abstract] [Full Text] [Related]
26. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity.
Mahady GB; Low Dog T; Barrett ML; Chavez ML; Gardiner P; Ko R; Marles RJ; Pellicore LS; Giancaspro GI; Sarma DN
Menopause; 2008; 15(4 Pt 1):628-38. PubMed ID: 18340277
[TBL] [Abstract][Full Text] [Related]
27. Menopause.
Nelson HD
Lancet; 2008 Mar; 371(9614):760-70. PubMed ID: 18313505
[TBL] [Abstract][Full Text] [Related]
28. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Grieco VS; Ehrlich K
Menopause; 2008; 15(1):51-8. PubMed ID: 18257142
[TBL] [Abstract][Full Text] [Related]
29. Black cohosh: a cause of abnormal postmenopausal liver function tests.
Joy D; Joy J; Duane P
Climacteric; 2008 Feb; 11(1):84-8. PubMed ID: 18202968
[TBL] [Abstract][Full Text] [Related]
30. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial.
Newton KM; Reed SD; LaCroix AZ; Grothaus LC; Ehrlich K; Guiltinan J
Ann Intern Med; 2006 Dec; 145(12):869-79. PubMed ID: 17179056
[TBL] [Abstract][Full Text] [Related]
31. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1.
Pockaj BA; Gallagher JG; Loprinzi CL; Stella PJ; Barton DL; Sloan JA; Lavasseur BI; Rao RM; Fitch TR; Rowland KM; Novotny PJ; Flynn PJ; Richelson E; Fauq AH
J Clin Oncol; 2006 Jun; 24(18):2836-41. PubMed ID: 16782922
[TBL] [Abstract][Full Text] [Related]
32. Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women.
Smith YR; Stohler CS; Nichols TE; Bueller JA; Koeppe RA; Zubieta JK
J Neurosci; 2006 May; 26(21):5777-85. PubMed ID: 16723535
[TBL] [Abstract][Full Text] [Related]
33. Fulminant hepatic failure associated with the use of black cohosh: a case report.
Lynch CR; Folkers ME; Hutson WR
Liver Transpl; 2006 Jun; 12(6):989-92. PubMed ID: 16721764
[TBL] [Abstract][Full Text] [Related]
34. Placebo effects mediated by endogenous opioid activity on mu-opioid receptors.
Zubieta JK; Bueller JA; Jackson LR; Scott DJ; Xu Y; Koeppe RA; Nichols TE; Stohler CS
J Neurosci; 2005 Aug; 25(34):7754-62. PubMed ID: 16120776
[TBL] [Abstract][Full Text] [Related]
35. Black cohosh (Actaea/Cimicifuga racemosa): review of the clinical data for safety and efficacy in menopausal symptoms.
Mahady GB
Treat Endocrinol; 2005; 4(3):177-84. PubMed ID: 15898823
[TBL] [Abstract][Full Text] [Related]
36. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials.
Kronenberg F; Fugh-Berman A
Ann Intern Med; 2002 Nov; 137(10):805-13. PubMed ID: 12435217
[TBL] [Abstract][Full Text] [Related]
37. Stress and the menstrual cycle: short- and long-term response to a five-day endotoxin challenge during the luteal phase in the rhesus monkey.
Xiao E; Xia-Zhang L; Ferin M
J Clin Endocrinol Metab; 1999 Feb; 84(2):623-6. PubMed ID: 10022427
[TBL] [Abstract][Full Text] [Related]
38. Age-related decrease in the opioid control of LH secretion during reproductive years in normal women.
Coiro V; Volpi R; Gramellini D; Cigarini C; Magotti MG; Caffarri G; Chiodera P
Gynecol Obstet Invest; 1997; 43(3):162-5. PubMed ID: 9127128
[TBL] [Abstract][Full Text] [Related]
39. Pulsatile patterns of gonadotropin release in subjects with and without ovarian function.
Yen SS; Tsai CC; Naftolin F; Vandenberg G; Ajabor L
J Clin Endocrinol Metab; 1972 Apr; 34(4):671-5. PubMed ID: 5012772
[No Abstract] [Full Text] [Related]
40. Neuroendocrinology of opioid peptides and their role in the control of gonadotropin and prolactin secretion.
Yen SS; Quigley ME; Reid RL; Ropert JF; Cetel NS
Am J Obstet Gynecol; 1985 Jun; 152(4):485-93. PubMed ID: 2990210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
